A Goupil

Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer Group

Matti Aapro, F.H. van Wijk, Giorgio Bolis et al. · Annals of Oncology · 2003 · 200 citations · Full text

Medicine, Gynecology, Oncology +8

Addition of Epirubicin As a Third Drug to Carboplatin-Paclitaxel in First-Line Treatment of Advanced Ovarian Cancer: A Prospectively Randomized Gynecologic Cancer Intergroup Trial by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group and the Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens

Andreas du Bois, B. Weber, Justine Rochon et al. · Journal of Clinical Oncology · 2006 · 196 citations · Full text

Medicine, Oncology, Pharmacology +17

Cisplatin in Combination With Either Gemcitabine or Irinotecan in Carcinomas of Unknown Primary Site: Results of a Randomized Phase II Study—Trial for the French Study Group on Carcinomas of Unknown Primary (GEFCAPI 01)

Stéphane Culine, Alain Lortholary, Jean‐Jacques Voigt et al. · Journal of Clinical Oncology · 2003 · 153 citations

Medicine, Oncology, Pharmacology +12

Interstitial brachytherapy for penile carcinoma: a multicentric survey (259 patients)

R Rozan, Éliane Albuisson, B Giraud et al. · Radiotherapy and Oncology · 1995 · 117 citations

Medicine, Oncology, Urology +12

Impact of FDG PET-CT imaging on the decision making in the biologic suspicion of ovarian carcinoma recurrence

Michaël Soussan, Myriam Wartski, P. Chérel et al. · Gynecologic Oncology · 2007 · 70 citations

Medicine, Nuclear Medicine, Oncology +17